国药股份 (600511.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(国药股份)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 12,122,142,562.3349,696,045,528.8736,529,666,779.3224,140,175,654.6411,226,301,799.6845,498,583,764.2434,542,529,953.5922,006,490,053.0311,060,099,734.74
 营业利润(元) 613,798,834.542,944,357,791.051,993,800,690.241,323,005,824.36573,523,223.292,694,923,451.031,970,141,349.431,191,410,918.98525,164,888.59
 利润总额(元) 613,536,476.752,930,890,244.951,986,053,916.101,324,508,245.18574,092,850.972,687,885,898.891,957,894,379.301,185,573,737.51524,834,951.41
 净利润(元) 495,118,467.382,334,470,740.611,581,910,864.841,062,676,754.05450,428,720.642,128,705,369.691,544,715,892.67932,598,435.88409,527,036.98
 归属于母公司股东的净利润(元) 459,454,518.022,145,998,746.541,462,295,886.22984,583,170.50414,428,624.821,964,057,559.331,431,630,184.32862,246,884.87373,846,882.93
盈利能力:
 销售毛利率(%) 7.038.037.747.737.708.408.127.817.17
 销售净利率(%) 4.084.704.334.404.014.684.474.243.70
 净资产收益率(%) 2.9814.3110.177.102.98----
 总资产报酬率ROA(%) 1.869.046.444.501.92----
 投入资本回报率ROIC(%) 2.4511.928.465.822.4412.179.275.702.48
营运能力:
 存货周转率(次) 2.7011.908.255.822.56----
 应收账款周转率(次) 1.586.765.673.941.94----
 总资产周转率(次) 0.391.601.200.830.39----
偿债能力:
 资产负债率(%) 45.2645.9746.8847.0545.5746.4447.7745.5646.12
 股东权益比率(%) 49.3048.6147.7047.3748.8248.0146.6648.4748.00
 已获利息倍数(倍) -20.30-22.24-84.77-58.20-24.11-92.20-72.64-57.17-28.51
 流动比率 2.082.041.991.992.052.021.942.012.00
 速动比率 1.751.741.681.691.721.711.641.691.65
发展能力:
 营业收入增长率(%) 7.989.235.759.701.50-2.090.73-0.316.93
 营业利润增长率(%) 7.029.261.2011.059.2110.129.2813.4426.84
 税后利润增长率(%) 10.879.262.1414.1910.8611.979.9912.5925.53
 净资产增长率(%) 10.9110.9810.2811.3811.2511.2311.0011.2412.08
 总资产增长率(%) 9.839.617.8913.979.395.716.522.2611.08

前瞻产业研究院